These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 19286581

  • 1. Cost-effectiveness of patient selection using penumbral-based MRI for intravenous thrombolysis.
    Earnshaw SR, Jackson D, Farkouh R, Schwamm L.
    Stroke; 2009 May; 40(5):1710-20. PubMed ID: 19286581
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness of CT perfusion for selecting patients for intravenous thrombolysis: a US hospital perspective.
    Jackson D, Earnshaw SR, Farkouh R, Schwamm L.
    AJNR Am J Neuroradiol; 2010 Oct; 31(9):1669-74. PubMed ID: 20538823
    [Abstract] [Full Text] [Related]

  • 3. Economic impact of using additional diagnostic tests to better select patients with stroke for intravenous thrombolysis in the United Kingdom.
    Earnshaw SR, McDade C, Chapman AM, Jackson D, Schwamm L.
    Clin Ther; 2012 Jul; 34(7):1544-58. PubMed ID: 22695225
    [Abstract] [Full Text] [Related]

  • 4. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D, Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology, Technology Assessment Committee of the Society of Interventional Radiology.
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.
    Tan Tanny SP, Busija L, Liew D, Teo S, Davis SM, Yan B.
    Stroke; 2013 Aug; 44(8):2269-74. PubMed ID: 23780955
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke.
    Ehlers L, Andersen G, Clausen LB, Bech M, Kjølby M.
    Stroke; 2007 Jan; 38(1):85-9. PubMed ID: 17122430
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of recombinant tissue-type plasminogen activator within 3 hours of acute ischemic stroke: current evidence.
    Boudreau DM, Guzauskas GF, Chen E, Lalla D, Tayama D, Fagan SC, Veenstra DL.
    Stroke; 2014 Oct; 45(10):3032-9. PubMed ID: 25190439
    [Abstract] [Full Text] [Related]

  • 8. Cost-Effectiveness of Intra-Arterial Treatment as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke.
    Leppert MH, Campbell JD, Simpson JR, Burke JF.
    Stroke; 2015 Jul; 46(7):1870-6. PubMed ID: 26012639
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of tissue-type plasminogen activator in the 3- to 4.5-hour time window for acute ischemic stroke.
    Tung CE, Win SS, Lansberg MG.
    Stroke; 2011 Aug; 42(8):2257-62. PubMed ID: 21719767
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A literature review of cost-effectiveness of intravenous recombinant tissue plasminogen activator for treating acute ischemic stroke.
    Joo H, Wang G, George MG.
    Stroke Vasc Neurol; 2017 Aug; 2(2):73-83. PubMed ID: 28736623
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A pharmacoeconomic assessment of recombinant tissue plasminogen activator therapy for acute ischemic stroke in a tertiary hospital in China.
    Yan X, Hu HT, Liu S, Sun YH, Gao X.
    Neurol Res; 2015 Apr; 37(4):352-8. PubMed ID: 25297471
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness of two endovascular treatment strategies vs intravenous thrombolysis.
    Bouvy JC, Fransen PS, Baeten SA, Koopmanschap MA, Niessen LW, Dippel DW.
    Acta Neurol Scand; 2013 May; 127(5):351-9. PubMed ID: 23278859
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A, Köhrmann M, Sobesky J, Cheng B, Rosenkranz M, Röther J, Schellinger PD, Ringleb P, Gerloff C, Fiehler J, Thomalla G.
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.